Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Cochlear Ltd

COH.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Medical Equipment, Supplies & Distribution ·

Australia Mid Cap Analyst: HOLD

Last Close

$94.60

▼ -0.25%

Market Cap $6.16B · Vol 370.74K

Key Metrics

P/E Ratio

25.37

FWD: 25.66

Market Cap

$6.16B

Mid Cap

Div Yield

4.39%

Semi-annual dividend

EPS Growth

-14.40%

YoY

RSI (14)

84.38

Momentum

Beta

0.96

vs Market

52W High

$221.83

53.57% below

52W Low

$62.84

48.08% above

Volume

370.74K

Avg 365.77K

P/B

10.07

Price-to-book

ROE

20.66%

Return on equity

Free Float

99.36%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Cochlear Ltd (COH.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does COH.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+7.00%

+8.44%

+40.01%

-32.94%

YTD

-48.75%

-56.34%

-40.53%

-46.66%

Financials & Valuation

TTM · Annual

Total Revenue	$1.54B
Net Income	$255.90M
Revenue Growth (YoY)	+0.52%
Gross Margin	73.89%
Operating Margin	22.74%
Net Profit Margin	16.51%
ROE	20.66%
ROA · ROIC	18.62% · 18.60%

P/E Ratio	25.37
Forward P/E (FY1)	25.66
PEG Ratio	5.52
P/S	8.37
P/B	10.07
P/FCF	146.00
EPS Growth	-14.40%
Outstanding Shares	65.40M

Technical Indicators

50-Day SMA	$83.99
200-Day SMA	$129.82
RSI (14)	84.38
Beta	0.96
52-Week High	$221.83
52-Week Low	$62.84

Volume Today	370.74K
Avg Daily Volume (30D)	365.77K
Relative Volume	1.01x
Volatility (10D)	19.32
Volatility (30D)	30.68
Free Float	99.36%

Analyst Consensus

HOLD

Current Price $94.60

Mean Target $88.66

52W Low$62.84 52W High$221.83

Current

Target

$62.84 $221.83

Current Analyst target

-6.29% downside risk · 17 analysts

Identifiers

ExchangeASX

FIGIBBG001S8MY64

ISINAU000000COH5

CountryAustralia

Sub-IndustryMedical Prosthetics

Earnings DateAug 17, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

STMN.S Straumann Holding AG +0.29% SOON.S Sonova Holding AG +0.92% OBCK.DE Ottobock SE & Co KgaA +0.00% 6699.HK Angelalign Technology Inc +0.00% EMBLA.CO Embla Medical hf +0.17%

Company Profile

Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services and Acoustics. The Cochlear Implants segment offers Cochlear implant systems. The Services segment offers sound processor upgrades, accessories and other. The Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.